Top 5 Oil Service Stocks To Invest In Right Now

I'm window shopping for shares again, and there are plenty of goodies for sale. Should I pop Petrofac� (LSE: PFC  ) into my basket?

Just the 'facs
These are tough times for oil stocks, with Brent crude falling below $100 a barrel on fears of a China and U.S. slowdown and weak demand from Europe. Oil services company Petrofac looked cheap last month, when you could buy it for around 拢15. Today, you would pay just 拢13.40. Is this a great time to buy?

Petrofac's share price is now down a meaty 20% over the last three months, despite signing a couple of lucrative contracts in April. Last week, it announced it had won the lion's share of a $3.7 billion deal to develop oil fields for the Abu Dhabi National Oil Company. That followed a $500 million contract from the Abu Dhabi Marine Operating Company. My suspicions that Petrofac is being unfairly punished by a wider market sell-off were confirmed by its recent full-year results, which revealed a 17% rise in profits, neatly matched with a 17% dividend hike.

Top 5 Promising Stocks To Own For 2015: Sagent Pharmaceuticals Inc.(SGNT)

Sagent Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, sources, and markets pharmaceutical products, principally injectable-based generic equivalents to branded products in the United States. It offers a range of products across anti-infective, oncolytic, and critical care indications in various presentations, including single-and multi-dose vials, pre-filled ready-to-use syringes, and premix bags. The company?s anti-infective products include Levofloxacin, a fluoroquinolone antibacterial for the treatment of various infections caused by susceptible bacteria in adults of age 18 years or older; and Cefepime, an antibiotic used to treat infections of the urinary tract, and skin and skin structure, as well as moderate to severe pneumonia, intra-abdominal infections, and as empiric therapy for febrile neutropenic patients. Its oncology products comprise Gemcitabine, a nucleoside metabolic inhibitor used for the treatment of ovarian, breast, lung, and panc reatic cancers; and Topotecan, a topoisomerase inhibitor for small cell lung cancer sensitive disease. The company also offers critical care products consisting of Adenosine, an antiarrhythmic used for the treatment of cardiac rhythm disturbances; and Heparin, an anticoagulant used to prevent and treat blood clotting during and after surgery and dialysis. As of December 31, 2011, it marketed 33 generic injectable products; and had a new product pipeline that included 36 products represented by 63 Abbreviated New Drug Applications (ANDAs). The company sells its products to pharmaceutical wholesale companies, which then distribute the products to end-user hospitals, long-term care facilities, alternate care sites, and clinics. The company was formerly known as Sagent Holding Co. and changed its name to Sagent Pharmaceuticals, Inc. in April 2011. Sagent Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Schaumburg, Illinois.

Advisors' Opinion:

• [By Roberto Pedone]

  Sagent Pharmaceuticals (SGNT) is a pharmaceutical company engaged in developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectables. This stock closed up 1.1% at $23.58 in Thursday's trading session.

  Thursday's Volume: 235,000
  
  Three-Month Average Volume: 128,231
  
  Volume % Change: 110%

  From a technical perspective, SGNT rose modestly higher here right above its 50-day moving average of $22.32 with above-average volume. This move pushed shares of SGNT into breakout territory, since the stock took out some near-term overhead resistance at $23.50. Shares of SGNT are now quickly moving within range of triggering another near-term breakout trade. That trade will hit if SGNT manages to clear its 52-week high at $24.27 with high volume.

  Traders should now look for long-biased trades in SGNT as long as it's trending above its 50-day at $22.32 and then once it sustains a move or close above its 52-week high at $24.27 with volume that's near or above 128,231 shares. If that breakout hits soon, then SGNT will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are its next major overhead resistance levels at $26.74 to its all-time high at $29.23.

• [By James Brumley]

  In no particular order…

  Sagent Pharmaceuticals (SGNT)

  Though Sagent Pharmaceuticals (SGNT) makes a few dozen generic drugs and has a similar number in the works, odds are good most investors couldn’t name a single one of them… and that’s a good thing for anyone on the hunt for cheap stocks from the pharma world.

• [By CRWE]

  Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, reported financial results for the quarter ended March 31, 2012.

• [By Rich Smith]

  Sagent Pharmaceuticals (NASDAQ: SGNT  ) �is recalling three lots of Vecuronium Bromide for Injection, 10mg (NDC number 25021-657-10). Vecuronium Bromide for Injection is a neuromuscular blocking agent used in addition to general anesthesia to facilitate insertion of endotracheal tubes, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.�

Top 5 Oil Service Stocks To Invest In Right Now: Marsh & McLennan Companies Inc. (MMC)

Marsh & McLennan Companies, Inc., a professional services company, provides advice and solutions in the areas of risk, strategy, and human capital. It operates in two segments, Risk and Insurance Services, and Consulting. The Risk and Insurance Services segment provides risk management and insurance broking, reinsurance broking, and insurance program management services for businesses, public entities, insurance companies, associations, professional services organizations, and private clients. The Consulting segment offers advice and services to the managements of organizations in the area of human resource consulting, comprising retirement and investments, health and benefits, outsourcing and talent; and strategy and risk management consulting, such as management, economic, and brand consulting. The company also provides investment consulting services for endowments and foundations in the United States; health and benefit recordkeeping, and employee enrollment technology; human resource knowledge, data, and solutions for professionals in various industries; and Medicaid policy consulting services. It principally serves customers in the United States, the United Kingdom, the Asia Pacific, and Continental Europe. Marsh & McLennan Companies, Inc. was founded in 1871 and is headquartered in New York, New York.

Advisors' Opinion:

• [By Ben Levisohn]

  Progressive (PGR) was downgraded from Strong Buy to Market Perform at Raymond James, while Marsh & McLennan (MMC) was cut to Outperform from Strong Buy.

• [By Dan Caplinger]

  The real test for Obamacare
  In any event, the biggest challenge that Obamacare faces is getting its Health Insurance Marketplace up and running by Oct. 1. Although private exchanges from Marsh & McLennan (NYSE: MMC  ) subsidiary Mercer as well as Towers Watson (NYSE: TW  ) have done a good job of getting Aetna, UnitedHealth, and other popular insurers to participate in their programs, the reception that public exchanges have gotten has been far less favorable. Without a smooth launch in less than three months, Obamacare could find itself facing much greater criticism than it is today.

• [By CRWE]

  Marsh & McLennan Companies, Inc. (NYSE:MMC) held its annual meeting of shareholders, at which the Company announced that its Board of Directors has voted to increase the Company�� quarterly cash dividend by 5 percent to $.23 per share on outstanding common stock.

Top 5 Oil Service Stocks To Invest In Right Now: CBS Corporation(CBS)

CBS Corporation, together with its subsidiaries, operates as a mass media company in the United States and internationally. The company?s Entertainment segment distributes a schedule of news and public affairs broadcasts, sports, and entertainment programming; produces, acquires, and distributes programming, including series, specials, news, and public affairs; produces and distributes theatrical motion pictures across various genres; and operates online content networks for information and entertainment. Its Cable Networks segment owns and operates multiplexed channels that offers subscription program services, including recently released theatrical feature films, original series, documentaries, boxing, mixed martial arts and other sports-related programming, and special events; and CBS College Sports Network, a 24-hour cable program service related to college sports. This segment also owns and manages Smithsonian Networks, which operates Smithsonian Channel, a basic cab le service in the United States. The company?s Publishing segment publishes and distributes adult and children?s consumer books in printed, audio, and digital formats. Its Local Broadcasting segment owns 29 broadcast television stations; owns and operates 130 radio stations in 28 U.S. markets and related online properties; and owns local Websites that combine television and radio local media brands online to provide the latest news, traffic, weather, and sports information, as well as local discounts, directories, and reviews. The company?s Outdoor segment sells advertising space on various media, including billboards, transit shelters and other street furniture, buses, rail systems, mall kiosks, stadium signage, and in retail stores. CBS Corporation was founded in 1986 and is headquartered in New York, New York.

Advisors' Opinion:

• [By Paul Ausick]

  And it�� not just lost subscriber revenue, but lost leverage over content providers. Time Warner blamed its disputes with CBS Corp. (NYSE: CBS) and Journal Communications over retransmission fees for its subscriber losses in the third quarter. Content producers like CBS are demanding higher retransmission payments from cable and satellite providers and dwindling subscriber numbers knock a sizeable chunk off providers��take.

Top 5 Oil Service Stocks To Invest In Right Now: Korian SA (KORI)

Korian SA is a France-based company that operates healthcare facilities and medical establishments. The Company's holdings include residential centers for the elderly (EHPAD), offering permanent social care and medical support; follow-up care and rehabilitation centers, including general and specialized centers. Korian SA's establishments are located in France, Italy and Germany via its subsidiaries, Segesta S.p.A., Phonix GmBH, Reacti Malt SAS, Sas La Normandie, Sa La Bastide de la tourne, Sas Mapadex La Roseraie, among others. In March 8, 2013, it finalized the acquisition of Curanum AG by Korian SA's Korian Deutschland AG. In February 2014, it announced the acquisition of a clinic in Florence and the sale of the psychiatry division in France comprising seven clinics and two nursing homes. Advisors' Opinion:

• [By Corinne Gretler]

  Korian (KORI) declined 3.8 percent to 24.35 euros. The merger with Medica will create the largest French operator of nursing homes. Medica holders will receive Korian stock valued at about 23.01 euros a share, the companies said in a statement today. That�� 15 percent above Medica�� closing price on Nov. 15. Medica shares added 2.4 percent to 20.50 euros.